Publication: SEOM clinical guidelines for anaplastic gliomas (2017).
Loading...
Identifiers
Date
2017-10-20
Authors
Balaña, C
Alonso, M
Hernandez-Lain, A
Hernandez, A
Perez-Segura, P
Pineda, E
Ramos, A
Sanchez, A R
Teixidor, P
Verger, E
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Springer
Metrics
Export
Abstract
The SEOM/GEINO clinical guidelines provide recommendations for radiological, and molecular diagnosis, treatment and follow-up of adult patients with anaplastic gliomas (AG). We followed the 2016 WHO classification which specifies the major diagnostic/prognostic and predictive value of IDH1/IDH2 missense mutations and 1p/19q codeletions in AG. The diagnosis of anaplastic oligoastrocytoma is discouraged. Surgery, radiotherapy and chemotherapy with PCV or TMZ are the first-line standard of care for AG with slight modifications according to molecular variables. A multidisciplinary team is highly recommended in the management of these tumors.
Description
MeSH Terms
Brain Neoplasms
Glioma
Humans
Glioma
Humans
DeCS Terms
Neoplasias encefálicas
Oligodendroglioma
Humanos
Oligodendroglioma
Humanos
CIE Terms
Keywords
Anaplastic astrocytoma, Anaplastic glioma, Anaplastic oligodendroglioma
Citation
Balañá C, Alonso M, Hernandez-Lain A, Hernandez A, Perez-Segura P, Pineda E, et al. SEOM clinical guidelines for anaplastic gliomas (2017). Clin Transl Oncol. 2018 Jan;20(1):16-21. doi: 10.1007/s12094-017-1762-7. Epub 2017 Oct 20. Erratum in: Clin Transl Oncol. 2018 Jul;20(7):937